10 Atrial Fibrillation Clinical Trials in Aurora, IL (2026)

Q: How do I join a clinical trial in Aurora?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Aurora research site will contact you.

Recruiting Atrial Fibrillation Studies in Aurora

NCT04088071Recruiting

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

The primary purpose of this Registry is to assess procedural safety and long-term effectiveness of catheter ablations in the treatment of subjects with PAF, PsAF, and VA. The Registry will utilize rea...

Aurora, IL20,000 participantsHeart Rhythm Clinical and Research Solutions, LLC

View Study Details

NCT05836987Recruiting

The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

REACT-AF is a multicenter prospective, randomized, open-label, blinded endpoint (PROBE design), controlled trial comparing the current Standard Of Care (SOC) of continuous Direct Oral Anticoagulation ...

Aurora, IL5,350 participantsJohns Hopkins University

View Study Details

NCT04045665Recruiting

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

The primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet t...

Aurora, IL3,200 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT07527299Recruiting

A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation

The purpose of this study is to assess how safe VARIPULSE catheter system is for treatment of a heart rhythm disease called persistent atrial fibrillation (PsAF) in participants who are having a cathe...

Aurora, IL920 participantsBiosense Webster, Inc.

View Study Details

NCT06436924Recruiting

Safety and Efficacy of Workflows of High Volume Single Operators in a LAAO Device Implant Procedural Day

SAFE HV is an observational, prospective, multi-center, non-randomized study evaluating real-world clinical experience of centers where a single procedural physician schedules eight or more left atria...

Aurora, IL678 participantsHeart Rhythm Clinical and Research Solutions, LLC

View Study Details

NCT06455098Recruiting

A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)

The purpose of this study is to demonstrate the safety and 12-month effectiveness of the BWI OMNYPULSE™ pulsed field ablation (PFA) platform for pulmonary vein isolation (PVI) in the treatment of part...

Aurora, IL440 participantsBiosense Webster, Inc.

View Study Details

NCT06699901Recruiting

Antibiotic Concentrations After MassivE Transfusion Study

Combat and civilian trauma frequently result in open wounds that are at risk for infection. Data from the Department of Defense Trauma Registry demonstrate that 74% of combat trauma casualties have an...

Aurora, IL417 participantsBrooke Army Medical Center

View Study Details

NCT07227532Recruiting

A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

The purpose of this study is to evaluate the long-term safety and effectiveness of the FDA approved VARIPULSE catheter system for pulmonary vein isolation (PVI) in the treatment of participants with s...

Aurora, IL276 participantsBiosense Webster, Inc.

View Study Details

NCT06324201Recruiting

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

Observational, multi-center, non-randomized, post-market study. This is a nested sub-study of the REAL AF Registry. Consecutive symptomatic drug refractory paroxysmal atrial fibrillation (PAF) patient...

Aurora, IL250 participantsHeart Rhythm Clinical and Research Solutions, LLC

View Study Details

NCT04963751Recruiting

ERAS in Pediatric & Adolescent Gynecology Preoperative Counseling

The Investigator propose a randomized trial that will assess whether participant involvement in pre-operative counseling for ERAS improves post-surgical pain scores. The Investigator will also assess ...

Aurora, IL60 participantsUniversity of Colorado, Denver

View Study Details

About Atrial Fibrillation Clinical Trials in Aurora

Atrial fibrillation (AFib) is the most common type of heart arrhythmia, causing an irregular and often rapid heartbeat. It significantly increases the risk of stroke, heart failure, and other complications. Treatment includes blood thinners, heart rate or rhythm control medications, and procedures like ablation.

There are currently 10 atrial fibrillation clinical trials recruiting participants in Aurora, IL. These studies are seeking a combined 31,591 participants. Research is being sponsored by Heart Rhythm Clinical and Research Solutions, LLC, Johns Hopkins University, Icahn School of Medicine at Mount Sinai and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atrial Fibrillation Clinical Trials in Aurora — FAQ

Are there atrial fibrillation clinical trials in Aurora?

Yes, there are 10 atrial fibrillation clinical trials currently recruiting in Aurora, IL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Aurora?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Aurora research site will contact you about next steps.

Are clinical trials in Aurora free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Aurora studies also compensate for your time and travel.

What atrial fibrillation treatments are being tested?

The 10 active trials in Aurora are testing new therapies including novel drugs, biologics, and treatment approaches for atrial fibrillation.

Data updated July 13, 2026 from ClinicalTrials.gov